Previous close | 15.39 |
Open | 15.16 |
Bid | 15.14 x 0 |
Ask | 15.26 x 0 |
Day's range | 15.16 - 15.16 |
52-week range | 15.16 - 30.15 |
Volume | |
Avg. volume | 12 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | 25 Jun 2024 - 01 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
The proceeds will be used primarily for debt paydown and general corporate purposes, Walgreens said. For the past year, the pharmacy chain has been gradually reducing its stake in the drug distributor. In November, Walgreens sold about $674 million worth of shares in Cencora and, prior to that, in August, sold some shares for proceeds of about $1.85 billion.
DEERFIELD, Ill., May 22, 2024--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that it has sold shares of Cencora, Inc. (NYSE: COR) pursuant to a share repurchase by Cencora in the amount of approximately $400 million.
The latest trading day saw Walgreens Boots Alliance (WBA) settling at $17.82, representing a -1.98% change from its previous close.